| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
Nordicus Partners Corp specializes in developing breakthrough therapeutics for diseases with unmet medical needs. The Company focuses on acquiring and developing drugs from biotech companies in the Nordics, a region known for its scientists, life...
Benzinga Rankings give you vital metrics on any stock – anytime.
You can purchase shares of NORDICUS PARTNERS CORP by Nordicus Partners Corp. (OTCQB:NORD) through any online brokerage.
There are no as such competitors for NORDICUS PARTNERS CORP by Nordicus Partners Corp..
There is no analysis for NORDICUS PARTNERS CORP by Nordicus Partners Corp. to provide a consensus price target.
The stock price for NORDICUS PARTNERS CORP by Nordicus Partners Corp. (OTCQB: NORD) is $4.04 last updated October 16, 2026 at 3:14 PM EDT.
There are no upcoming dividends for NORDICUS PARTNERS CORP by Nordicus Partners Corp..
NORDICUS PARTNERS CORP by Nordicus Partners Corp. does not have any upcoming earnings scheduled.
There is no upcoming split for NORDICUS PARTNERS CORP by Nordicus Partners Corp..
NORDICUS PARTNERS CORP by Nordicus Partners Corp. is in the Health Care sector and Biotechnology industry. They are listed on the OTCQB.